Vermillion Posts Q3 Revenue Decline, Acquires Assets of Correlogic | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion today announced that total revenues in the third quarter were down 23 percent year over year despite an 81 percent uptick in product revenues.

The company also said that it has purchased "substantially all" of the assets of Correlogic Systems, a company currently in Chapter 11 bankruptcy protection.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.